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The development of decellularised scaffolds for small diameter vascular grafts is hampered by their
limited patency, due to the lack of luminal cell coverage by endothelial cells (EC) and to the low tone of
the vessel due to absence of a contractile smooth muscle cells (SMC). In this study, we identify a pop-
ulation of vascular progenitor c-Kitþ/Sca-1- cells available in large numbers and derived from immuno-
privileged embryonic stem cells (ESCs). We also deﬁne an efﬁcient and controlled differentiation protocol
yielding fully to differentiated ECs and SMCs in sufﬁcient numbers to allow the repopulation of a tissue
engineered vascular graft. When seeded ex vivo on a decellularised vessel, c-Kitþ/Sca-1-derived cells
recapitulated the native vessel structure and upon in vivo implantation in the mouse, markedly reduced
neointima formation and mortality, restoring functional vascularisation. We showed that Krüppel-like
transcription factor 4 (Klf4) regulates the choice of differentiation pathway of these cells through b-
catenin activation and was itself regulated by the canonical Wnt pathway activator lithium chloride. Our
data show that ESC-derived c-Kitþ/Sca-1-cells can be differentiated through a Klf4/b-catenin dependent
pathway and are a suitable source of vascular progenitors for the creation of superior tissue-engineered
vessels from decellularised scaffolds.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Therapies for coronary and peripheral vascular diseases often
involve vascular grafts to restorebloodperfusion. In clinical practice,
the transplantation of an autologous vessel is the primary choice;
however, almost 40% of patients lack autologous vessels of an
adequate quality. To overcome this limitation, artiﬁcial alternatives
have been devised, including synthetic expanded polytetraﬂuoro-
ethylene (ePTFE) and Dacron grafts and decellularisation of natural
vessels [1]. In particular, the development of decellularised vessel
scaffolds allows for the creation of an ‘off-the-shelf’ material
combining the characteristics of the natural vessels and as ayal School of Mines, Imperial
.
, King's College London, 125
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Ltd. This is an open access article usubstrate for cell adhesion and growth with low immunogenicity.
Despite their promise, the application of decellularised vessel scaf-
folds in the clinic has been hampered by inadequate long-term
patency due to thrombosis and neointimal hyperplasia1. We previ-
ously showed in an animal model that the patency of decellularised
vessels is limited due to the lack of adequate endothelialisation [2].
The outcome of the graft was greatly improved by the local appli-
cation of vascular endothelial growth factor (VEGF), which induced
the local recruitment of endothelial progenitor cells to the scaffold
[2]. For the same reason, the seeding of the luminal side of the
scaffold with endothelial cells has been demonstrated to improve
graft success rate by ensuring a non-thrombogenic surface of con-
tact with the blood. Similarly, the seeding of smooth muscle cells
(SMCs) in the media of the decellularised vessel was shown to
improve the mechanical stability of the graft and its compliance
[3,4]. However, the use ofmature endothelial cells (ECs) and SMCs is
hampered by their limited availability from an autologous source
and low proliferation rate. For this reason, the exploitation of the
immuno-privileged and plastic embryonic stem cells (ESCs) isnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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rise to a high number of differentiated cells including ECs and SMCs,
provided themechanisms regulating the differentiation process are
well understood and controlled.
In this study, we focused on the isolation of an abundant and
clinically relevant c-Kit positive/Sca1-negative (c-Kitþ/Sca-1-)
vascular progenitor population from ESCs and their differentiation
to both ECs and SMCs.We then applied these cells to repopulate the
decellularised scaffold for vascular graft. The c-Kit antigen has
previously been used to deﬁne progenitor cells in the human and
mouse heart where they participate to repair after myocardial
infarction [5] and form both ECs and SMCs [6,7]. Regulating the
choice of differentiation pathway in progenitor cells is funda-
mental: (a) to obtain a highly differentiated and pure population for
tissue engineering; (b) for the maintenance of the physiological
state once the vessel is grafted and (c) to manipulate the progres-
sion of the in vivo re-endothelialization of the vascular graft. For
vascular progenitor cells, the mechanisms have been only partially
elucidated. In this paper, we focused on Krüppel-like factor 4 (Klf4),
which is known to play an atheroprotective function in the vessel
[8e12] and participate to anti-inﬂammatory [13e16] and shear
stress response [17,18]. We also investigated the interaction of Klf4
with Wnt/b-catenin signalling, which plays an important role in
vasculature development and endothelial function/remodeling
[19e21] through the shufﬂing of b-catenin and activation of T cell
factor (TCF) target genes [13,14,22]. Understanding the differenti-
ation mechanisms underpinning c-Kitþ/Sca-1- cell fate is crucial
for their use as a cell source for vascular grafts.
2. Material and methods
For expanded Materials and methods, refer to the Supplemental
Methods provided.
2.1. Cell culture, isolation and differentiation
Mouse ESCs (ES-D3 cell line, American Type Culture Collection
[ATCC]) and isolated c-Kitþ/Sca1-cells were cultured as previously
reported [23]. Differentiation was induced by plating c-Kitþ/Sca1-
cells on collagen IV-coated ﬂasks in presence of differentiation me-
dium (DM; a-MEM containing 10% FBS, 0.2 mM 2-mercaptoethanol,
100 U/ml penicillin, and 100 mg/ml streptomycin; Invitrogen) con-
tainingeither VEGF (50 ng/ml, Peprotech) or platelet-derived growth
factor (PDGF, 20 ng/ml, Sigma) for up to 21 days. The endothelial
differentiation protocol was improved with the application of shear
stress between Day 3 and 5 using an orbital shaker.
2.2. Decellularised vessel preparation and seeding
The preparation of the decellularised vessels was performed as
previously described [2] treating the descending aorta with 0.075%
SDS for 2 h. c-Kitþ ECs were seeded using a bioreactor where the
grafts were ﬁxed between two needles and the bioreactor was set
up in a standard incubator at 37 C. Scaffolds were preconditioned
for 2 h with the indicated coating. 2  106 c-Kitþ EC were then
injected and allowed to seed for 12 h at a continuous rotational
movement before initial ﬂow was set up. For double seeded scaf-
folds, a second seeding step was performed with 1  106 c-Kitþ
derived SMCs. After seeding, medium ﬂow rate was adjusted
stepwise to reach a shear stress of 30 dyn/cm2. Vessels were har-
vested on Day 5 and then used for further analysis ex vivo or
immediately grafted to animals. Decellularised vessels were used as
a control.
Picrosirius collagen and Miller's elastin staining was performed
to assess the collagen content in the tissue-engineered vessel.2.3. Decellularised and tissue-engineered vessel grafting to the right
carotid artery
Mice were anesthetised and the middle portion of the carotid
artery was ligated and dissected between the two ties. The graft
was interposed as previously described using a two-cuffs based
system [2].
A total of 56, 28 and 13 mice were transplanted respectively
with non-seeded, c-Kitþ EC seeded, and c-Kitþ ECsþ SMCs seeded
grafts, respectively. Survival was monitored for up to 56 days and
tissues for patency monitoring were collected at 2, 4 and 8 weeks.
Mice underwent magnetic resonance imaging (MRI) on a 7T
Agilent MRI scanner tuned to 400 MHz 1H frequency.
2.4. Lesion measurement
For en face staining, the tissue-engineered vessels were cut
longitudinally and mounted with the lumen facing up before in-
cubationwith Alexa Fluor 488 phalloidin and/or 40-6-Diamidino-2-
phenylindole (DAPI). Lesion measurement was performed by
staining cross-sections obtained at the centre of the graft with
hematoxylin and eosin (H&E stain).
2.5. Statistical analysis
Data were analysed with GraphPad Prism 5.02 program using
ANOVA and two-tailed student's t-test for two-groups or pair-wise
comparisons. The results were expressed as the mean ± standard
error of the mean (SEM).
3. Results
3.1. Isolated c-Kitþ/Sca-1- cells represent a novel population of
ESC-derived vascular progenitor cells
ESCs cultured on collagen IV became adherent and elongated
(Fig. 1ai) and contained high numbers of c-Kitþ/Sca-1- cells (about
50% of the total, Fig. 1aii). c-Kitþ/Sca-1- cells were isolated by ﬂow
cytometry (FACS) and stimulated with VEGF in combination with
shear stress or with PDGF-BB (Fig.1aiiieiv). In the presence of VEGF,
the cells assumed cobblestone-like features (Fig. 1aiii) and
expressed EC markers CD31, Flk-1 and VE-cadherin at both mRNA
(Fig. 1bi) and protein level (Fig. 1bii). Flow cytometry analysis
showed that under these culture conditions, the population
expressing endothelial markers accounted to about the 80% of the
cells (Fig. 1biii). Functional differentiation was demonstrated by
Matrigel assay and Ac-LDL uptake (Fig. 1biv and Supplemental
Fig. 1). When cultured with PDGF-BB, the cells grew in size,
assuming a polygonal shape (Fig. 1aiv), and started overexpressing
SMC speciﬁc genes (Fig. 1ci) and proteins (Fig. 1cii-iii). Image
analysis indicated a differentiation efﬁciency nearing 100%
(Supplemental Fig. 2).
3.2. c-Kitþ derived vascular cells repopulated the decellularised
graft and improved in vivo outcome
When suitable patient-derived vessels are unavailable for vessel
graft procedures, decellularised vessels offer an attractive alterna-
tive. Our lab has developed an efﬁcient mouse model mimicking
the clinical situation whereby the aorta is harvested and decellu-
larised ex vivo before being grafted in themouse carotid artery, thus
simulating the patient situation during vessel surgery [2]. In this
study, we aimed to exploit the potential of c-Kitþ derived cells for
pre-clinical application by seeding them on the decellularised
scaffold and implanting it in the mouse model of vessel graft. We
Fig. 1. Isolation and differentiation of c-Kitþ/Sca-1- cells. a: Morphology of differentiated ESC (ai) and ﬂow cytometry strategy for the isolation of c-Kitþ/Sca-1- subpopulation (red
box, aii). Addition of VEGF and application of shear induced endothelial phenotype (EC, aiii) while PDGF induced smooth muscle cells phenotype (SMC, aiv). b: VEGF treated cells
overexpressed EC markers as shown by real time-PCR (bi), immunocytochemistry (bii) and ﬂow cytometry (biii). Functional differentiation was assessed by in vitro tube formation
assay (biv). c: PDGF treatment induced expression of SMC markers, as shown at mRNA level (ci) and by immunocytochemistry (cii) and western blot analysis (ciii). Data are
expressed as fold-change over Day 0 (dotted lines). Scale bars: 200 mm (a), 25 mm (bii), 100 mm (biv), 50 mm (cii) *P < 0.05; **P < 0.01; ***P < 0.001 vs. Day 0. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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protocol leading to a homogenous luminal attachment of ECs on the
graft. Application of shear force was initiated at a rate of 3 dyn/cm2and then gradually increased to reach the physiological shear stress
of 30 dyn/cm2. The protocol proved crucial for the cell attachment
to the lumen; the best coverage was obtained when the ﬂow was
P. Campagnolo et al. / Biomaterials 60 (2015) 53e6156increased hourly over the ﬁrst 24 h (Fig. 2a and b). Next, the
decellularised vessel was coated with gelatin or ﬁbronectin and
results showed that cell attachment was vastly improved after
coating, upon the application of the shear (Fig. 2c). Under these
conditions, c-Kitþ ECs efﬁciently attached to the luminal surface of
the vessel, producing a continuous monolayer of CD31þ ECs
(Fig. 2d) that responded to the application of physiological shear
stress by aligning to the direction of the ﬂow and becoming elon-
gated (Fig. 2e). Collagen and elastin staining showed that cell
seeding improved the extracellular matrix content (Fig. 2f).
When decellularised vessels seeded with c-Kitþ ECs were
implanted in a model of vascular graft, we observed increased re-
sidual lumen area (Fig. 2g) and reduced neointimal formation
(Fig. 2h). Overall, 100% of the seeded grafts were patent at 4 weeks,
compared with 60% of the control grafts (Supplemental Table 1). As
reported in Supplemental Table 2, the major complication observed
in mice grafted with decellularised vessel was thrombus formation,
which was completely abolished by graft seeding. To further
improve the design of the graft and to ameliorate the performance
in terms of graft rupture (accounting for 28.6% of the graft failures
in c-Kit-EC seeded vessels, Supplemental Table 2), we seeded the
decellularised vessels with a combination of c-Kitþ derived SMCs.
Seeding of the graft with ECs only or ECsþ SMCs signiﬁcantly
increased the survival of the mice (Fig. 2i) by reducing graft oc-
clusion (Fig. 2j). Survival rate was increased to over 80% in the
double seeded vessels (Fig. 2i). MRI conﬁrmed the superior per-
formance of ECsþ SMCs seeded vessels (Fig. 2k).
Together, these data indicate that the application of progenitor-
derived vascular cells for repopulation of vascular grafts is feasible
and that seeding dramatically reduces lumen occlusion and ulti-
mately mortality.
3.3. Klf4 induces EC differentiation and inhibits SMC differentiation
Data presented so far demonstrated that c-Kit-derived vascular
progenitor cells can give rise to both ECs and SMCs and that their
application to tissue-engineered vascular grafts can signiﬁcantly
improve in vivo performance and survival. Next we studied the
underlying molecular mechanisms determining the choice of dif-
ferentiation pathway of vascular progenitor cells. The under-
standing of the regulation of progenitor cell differentiation is
fundamental for the development of strategies aimed at the
reduction of graft complications due to the over-proliferation of
SMC and the lack of EC coverage.
We established that Krüppel-like transcription factor 4 (Klf4)
was regulated upon differentiation. In particular, Klf4 expression
was strongly induced during EC differentiation and downregulated
during SMC differentiation (Fig. 3a). Upon adenoviral over-
expression of Klf4 (Supplemental Fig. 3), we observed increased EC
commitment of the c-Kitþ derived vascular progenitors as shown
by increased tube-formation capacity (Fig. 3b). Klf4 overexpression
led to increased expression of EC markers CD31, VE-cadherin and
eNOS at both RNA and protein level, and a concomitant reduction in
SMC markers (Fig. 3c and d). Additionally, lentiviral knockdown of
Klf4 (Supplemental Fig. 3) resulted in increased expression of SMC
and the inhibition of EC markers at both mRNA and protein levels
(Fig. 3e and f). These results highlight the central role of Klf4 in the
determination of the differentiation fate in c-Kit-derived vascular
progenitor cells.
3.4. Klf4 and canonical Wnt pathway interact to determine c-Kitþ
cell differentiation fate
The canonical Wnt pathway has been implicated in the fate
decision of stem cell-derived vascular cells [17,18,21,24]. Klf4 hasalso been shown to interact with b-catenin in the nucleus in the
context of tumour growth [25,26]. In our study, we found that Klf4
overexpression led to a nuclear accumulation of b-catenin as shown
by confocal imaging and western blot analysis (Fig. 4a and b); this
effect was reversed when Klf4 expression was inhibited (Fig. 4c).
The reported downstream effectors of the Wnt pathway Axin2, ID2
and Cyclin D1 were altered by Klf4 overexpression and knockdown
(Supplemental Fig. 4).
Treatment of cells with lithium chloride (LiCl), a Wnt pathway
and b-catenin activator, resulted in an increase of Klf4 expression
and EC markers and a reduction of SMC markers expression
(Fig. 4c), mimicking the effects of the exogenous upregulation of
Klf4 described above. Conversely, when b-catenin expression was
knocked down, EC differentiation was impaired: EC marker
expression was reduced alongside increased levels of SMC markers
(Fig. 4d and e).
To conﬁrm the importance of Klf4 in the activation of the Wnt
pathway, we established that the activity of the b-catenin-depen-
dent TCF promoter was ablated by knockdown of Klf4, as shown by
TOP-ﬂash luciferase assay (Supplemental Fig. 5). Interestingly, LiCl-
dependent EC marker upregulation was reduced in Klf4-deﬁcient
cells (Fig. 4f). Conversely, b-catenin knockdown blunted the Klf4-
induced upregulation of CD31 expression and downregulation of
SMA (Fig. 4g). Our results reveal an interesting relationship be-
tween Klf4 expression and b-catenin activation, whereby LiCl in-
duction of EC differentiation is mediated by Klf4 and Klf4 requires
b-catenin to upregulate EC markers. This observation is in line with
a previously reported mechanism showing that canonical Wnt
activation directly increases Klf4 expression [16], indicating that
Klf4 might partially mediate b-catenin activation. However, at this
stage further studies are required to elucidate in the exact
mechanism.
4. Discussion
Acute coronary obstruction requires arterial bypass surgery
where an autologous vessel is grafted to the narrowed artery
[15,16,27]. When autologous grafts are unavailable, the decellular-
isation of native vessels can potentially provide alternative material
endowed with comparable characteristics [28e32]. However, the
delayed endothelialisation dramatically increases the potential for
neointimal formation [2,8e12], which creates the need for a suit-
able source of transplantable ECs. Stem cell-derived vascular cells
allow the generation of a greater number of ECs compared to
mature sources that could be exploited in the clinical practice
owing to their privileged immunogenic proﬁle [19e21,33]. In this
study, we provide evidence that ESC-derived c-Kitþ/Sca-1- cells are
a suitable source of ECs and SMCs and can therefore be considered
bona ﬁde vascular progenitor cells. In particular, we demonstrated
the clinical relevance of ESC-derived cells in tissue engineering by
seeding them on a decellularised scaffold using a bioreactor and
applying it to a model of vascular graft. The optimised graft prep-
aration and seeding allowed the creation of an improved cellu-
larised graft displaying a continuous luminal layer of endothelial
cells and a robust SMC layer. This improved survival and patency
and reduced graft failure by avoiding thrombus, neointima devel-
opment, and graft rupture [32,34,35]. Previously, our group has
shown that decellularised vessels seeded with endothelial and
smooth cells derived from adult reprogrammed cells displayed
increased patency and survival, compared to their non-seeded
counterparts [4]. In the present study, we explored the applica-
tion of embryonic derived c-Kitþ cells as a cell source of endothelial
and smooth muscle cells. This approach has the potential advan-
tage to provide a relatively easier protocol to obtain larger number
of vascular cells with high purity. Additionally, the implantation of
Fig. 2. Ex vivo seeding of decellularised vessel scaffolds and in vivo grafting. Two protocols were followed to increase the shear from 3 to 30 dyn/cm2 in the tissue engineered grafts
after luminal seeding of ECs: ‘daily step-wise’ (protocol A) or ‘hourly step-wise’ (protocol B) (a); cell retention was quantiﬁed in (b). Effect of PBS or gelatin or ﬁbronectin coating on
cell retention in static (empty bars) and shear (grey bars) was quantiﬁed in (c). c-Kitþ ECs formed a homogeneous CD31þ luminal monolayer on the decellularised vessel (d) and
elongate in response to shear (e). Picosirius staining for collagen and Miler's elastin staining of decellularised vessels showed improved matrix deposition after cell seeding (f).
In vivo implantation of vessels seeded with c-Kitþ ECs showed improved lumen patency (g) and reduced neointima formation (h). Both the seeding with ECs and with the
combination of ECs and SMCs (ECsþ SMCs) increased the survival of grafted animals (i) and reduced vessel obstruction (j). MRI detection of the blood ﬂow in the normal carotid (k,
i), an occluded carotid grafted with a decellularised vessel (k, ii) and a patent carotid grafted with ECsþ SMCs seeded scaffolds at Day 2 (k, iii), and 2 weeks (k, iv). Red arrows
indicate the position of the grafts. Scale bars: 50 mm (d, f, l) and 100 mm (e). *P < 0.05; **P < 0.01; ***P < 0.001. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
P. Campagnolo et al. / Biomaterials 60 (2015) 53e61 57
Fig. 3. Effect of Klf4 expression in differentiating c-Kitþ cells. VEGF treatment induced and PDGF decreased Klf4 expression (a, vs. Day 0, dotted line). Overexpression of Klf4
(AdKlf4) increased EC differentiation and reduced SMC markers as shown by tube-formation (b), PCR (c) and western blot (d), as compared to control virus (AdCTL). Klf4 knockdown
(ShKlf4) reduced endothelial marker expression and increased levels of SMC markers at RNA (e) and protein level (f) *P < 0.05, **P < 0.001, ***P < 0.0001 vs. control.
P. Campagnolo et al. / Biomaterials 60 (2015) 53e6158the vascular grafts prepared using c-Kitþ progenitors-derived EC
and SMC determined better survival rate (over 80%) compared to
the adult cell-derived grafts (60%). Furthermore, the use of an
abundant population of mouse progenitor cells characterised by
the expression of the c-Kit antigen makes our ﬁndings easily
translatable to their human counterpart. The c-Kit antigen is
expressed in several progenitor populations in adult human tissuesincluding the heart where they act as a reservoir of cardiomyocytes,
ECs and SMCs [5,36].
A thorough understanding of the molecular mechanisms
implicated in the differentiation of stem cells into the vascular cell
lines used for the creation of the grafts will help the development of
strategies to improve the long-term performance of vascular grafts.
In this study, we present a novel mechanism involving the
Fig. 4. Klf4 and canonical Wnt pathway are interconnected in the determination of c-Kitþ cells differentiation. Confocal imaging showing the membrane localisation of b-catenin in
control cells (AdCTL) and nuclear accumulation in Klf4 overexpressing cells (AdKlf4, a). Western blot conﬁrmed b-catenin activation by AdKlf4 (b) and inhibition by ShKlf4 (c). LiCl
(b-catenin activator) induced Klf4 and EC marker expression and reduced the SMC marker expression in a concentration-dependent manner (c: vs. NaCl, dotted line). Knockdown of
b-catenin (Shbcat) impaired VEGF-dependent EC differentiation and increased SMC markers (d, vs. control virus: dotted line and e). LiCl-induced increase of EC markers was
inhibited by Klf4 knockdown (f, ShKlf4). Klf4-induced EC marker upregulation and SMC marker downregulation is ablated by b-catenin knockdown (g). *P < 0.05; **P < 0.01. Scale
bars: 10 mm (a). *P < 0.05; **P < 0.01 and ***P < 0.001.
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P. Campagnolo et al. / Biomaterials 60 (2015) 53e6160transcription factor Klf4 and the canonical Wnt pathway that could
be exploited in future to improve the levels of endothelialisation of
vascular grafts and control SMC overgrowth leading to neointimal
growth. In particular, we described the central role of the tran-
scription factor Klf4 in driving differentiation preferentially to-
wards the EC lineage and therefore reducing SMC differentiation.
This was in line with previous ﬁndings showing that Klf4 is upre-
gulated by shear stress [18], a typical EC differentiation stimulus,
and that Klf4 regulates eNOS [10,14,31,37] and VE-cadherin
expression [16] and inhibits SMC maturation [38]. Furthermore, a
recent publication showed that Klf4 played a fundamental role in
the maintenance of the vascular phenotype of endothelial pro-
genitor cells [39]. Interestingly, the Klf4-induced canonical Wnt
pathway activation and effect on differentiation was mimicked by
LiCl, a Wnt activator. These results are in line with previous studies
describing the importance of Wnt in the development of the em-
bryonic vasculature [20,21]. These in vitro studies create the foun-
dation for future investigations on the application of Klf4 and b-
catenin overexpression/stimulation in the context of vascular graft
in vivo in order to ameliorate the graft endothelialization, as pre-
viously demonstrated for VEGF administration [2].
The data presented described for the ﬁrst time the vasculogenic
potential of ESC-derived c-Kitþ cells and their suitability as a source
of vascular cells for the creation of alternative grafts. We provided a
novel insight into the mechanism regulating their differentiation,
thus providing the translational potential for this stem cell therapy.
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